5WK0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aligos Therapeutics Inc

Watchlist Manager

Watchlist

Price: 5.31 EUR -0.38% Market Closed

Market Cap: €32.7m

	Aligos Therapeutics Inc F:5WK0	US
D	Deutsche Bank AG XHAM:DBK	DE
B	BJ's Wholesale Club Holdings Inc F:8BJ	US
F	Fulton Financial Corp F:FU5	US
C	Credicorp Ltd F:D8V	PE
C	Costco Wholesale Corp DUS:CTO	US
C	China Shenhua Energy Co Ltd SWB:IKF	CN
	Subsea 7 SA F:SOC	UK
A	Antofagasta PLC XMUN:FG1	UK
B	Box Inc F:3BX	US
W	Weichai Power Co Ltd F:WI4	CN
A	Advanced Micro Devices Inc XBER:AMD	US
	Ariana Resources PLC LSE:AAU	UK
P	Pernod Ricard SA DUS:PER	FR
M	Mitsubishi Corp F:MBI	JP
	MTN Group Ltd F:LL6	ZA

Profitability Summary

Aligos Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Negative Operating Margin

-4 025%

Negative 3Y Average Operating Margin

-1 666%

Declining Operating Margin

-586% > -4 025%

Negative Net Margin

-1 107%

Negative 3Y Average Net Margin

-1 396%

Declining Net Margin

-593% > -1 107%

Negative Free Cash Flow Margin

-3 794%

Negative 3Y Average Free Cash Flow Margin

-1 553%

Declining Free Cash Flow Margin

-582% > -3 794%

Negative ROE

-197%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-753%

Declining ROIC

-425% > -1 031%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.